So the antioxidant and preservative-boosting roles are the well supported ones while the calming benefit is plausible but thinly evidenced
doi: 10.1038/ncprheum0531 54 TremlREKatayamaHTCaldonazoTPereiraTSMalbouissonLMSCarmonaMJCet al
Department of Medicine, University Medical Centre Mainz, Johannes Gutenberg University, Mainz, Germany, Mainz, Germany Background: Fib-4 was developed as a non-invasive biomarker to predict advanced fibrosis in other liver disease and was consequently adopted in nonalcoholic fatty liver disease (NAFLD) / nonalcoholic steatohepatitis (NASH) by international guidelines
Cagrilintide has not been approved yet by the FDA
Clinical studies on this ingredient showed no irritation, sensitization, or phototoxicity
As the OCR noted, it's a 'MILKY AND SMOOTH TEXTURE'